Artificial intelligence is moving beyond broad models and experimental tools. It is increasingly being applied to specific problems in defined industries where it can create measurable value. This includes sectors such as healthcare, enterprise software, defense, and industrial automation. The focus is shifting from general AI to specialized systems that improve performance, streamline operations, or… Continue reading From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Mark MCKelvie
From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Artificial intelligence is moving beyond broad models and experimental tools. It is increasingly being applied to specific problems in defined industries where it can create measurable value. This includes sectors such as healthcare, enterprise software, defense, and industrial automation. The focus is shifting from general AI to specialized systems that improve performance, streamline operations, or… Continue reading From Healthcare to Automation: Investing In Next AI Wave (IZOZF, AI, DCBO, PATH)
Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
US Edition Member Subscribe Switch edition MEDICUS PHARMA LTD. Add to a listPDF Report Medicus Pharma Ltd. Stocks MDCX CA58471K2020 Pharmaceuticals Real-time Estimate Cboe BZX 03:00:00 2026-09-17 pm EDT 5-day change 1st Jan Change 0.1760 USD +12.68% +8.18% -88.59% Sep. 10 Medicus Pharma Publishes Abridged Final Phase 2 SkinJect Clinical Study Report Results Identifying 200… Continue reading Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
In the biotech sector, meaningful news often serves as the spark that brings smaller companies into sharper investor focus. Clinical readouts, regulatory decisions, and strategic acquisitions can materially shift the outlook for a business that may have otherwise flown under the radar. These developments not only shape the future of a company’s pipeline but can… Continue reading Medicus Pharma Ltd. (NASDAQ: MDCX) Builds Momentum With Antev Acquisition and Pipeline Progress
Altcoin Season Meets Wall Street: Four Equities to Watch (DBKSF, BMNR, DJT, DFDV)
Crypto is once again showing signs of life. After spending much of the year grinding sideways, the market has shifted in recent weeks with Ethereum climbing back above $4,000 and money beginning to spill over into smaller tokens. The Altcoin Season Index, a closely watched gauge of capital rotation, flipped positive in late August, fueling… Continue reading Altcoin Season Meets Wall Street: Four Equities to Watch (DBKSF, BMNR, DJT, DFDV)
Five Stocks Turning Crypto Strategies Into Real Shareholder Opportunities (VVPR, DJT, UPXI, BMNR, SBET)
As the summer winds down, one market segment is starting to grab serious attention: digital asset treasuries. Public companies are increasingly adding cryptocurrencies such as Bitcoin, Ethereum, and Solana to their balance sheets as part of long-term strategies. What was once seen as a fringe experiment is now scaling, with corporate treasuries already holding more… Continue reading Five Stocks Turning Crypto Strategies Into Real Shareholder Opportunities (VVPR, DJT, UPXI, BMNR, SBET)
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
Biotech is once again capturing investor attention, with small-cap companies in particular drawing focus for their potential to deliver breakthrough therapies and regulatory milestones. Over the past six months, clinical-stage biotechs reporting meaningful data have moved an average of nearly 12 percent in a single day, showing how quickly the market reacts to progress. With… Continue reading Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
Altcoin Season Meets Wall Street: Four Equities to Watch (DBKSF, BMNR, DJT, DFDV)
Crypto is once again showing signs of life. After spending much of the year grinding sideways, the market has shifted in recent weeks with Ethereum climbing back above $4,000 and money beginning to spill over into smaller tokens. The Altcoin Season Index, a closely watched gauge of capital rotation, flipped positive in late August, fueling… Continue reading Altcoin Season Meets Wall Street: Four Equities to Watch (DBKSF, BMNR, DJT, DFDV)
Five Stocks Turning Crypto Strategies Into Real Shareholder Opportunities (VVPR, DJT, UPXI, BMNR, SBET)
As the summer winds down, one market segment is starting to grab serious attention: digital asset treasuries. Public companies are increasingly adding cryptocurrencies such as Bitcoin, Ethereum, and Solana to their balance sheets as part of long-term strategies. What was once seen as a fringe experiment is now scaling, with corporate treasuries already holding more… Continue reading Five Stocks Turning Crypto Strategies Into Real Shareholder Opportunities (VVPR, DJT, UPXI, BMNR, SBET)
Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)
The biotech sector is entering a pivotal phase fueled by scientific breakthroughs, accelerated regulatory approvals, and a surge of strategic dealmaking. The Nasdaq Biotechnology Index has posted strong gains, signaling renewed investor confidence. The FDA is clearing a record number of novel therapies, while global mergers and acquisitions have climbed past $105 billion, a seven… Continue reading Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)